Monoclonal Antibodies

Our Media are designed for small- and large-scale biomanufacturing and feature full and easy scalability.

Fermentation is mostly extracellular activity and is brought with the help of enzymes released by the microorganisms. The Fermenter is designed to meet all process requirement for micro-organism to achieve maximum growth and productivity. Features:
• Fully automated or semi-automated models
• 21 CF...

For optimal clarification of biopharmaceutical manufacturing fluids, 3M’s extensive line of depth filters is versatile and adaptable for many processes. Our pharmaceutical-grade filters have high contaminant-holding capacity and provide economical filtration with reliable particle reduction.

Polpharma Biologics portfolio includes 7 biosimilars and 2 innovative molecules.

Prolgolimab is the original fully human anti-PD1 monoclonal antibody for the treatment of advanced melanoma, advanced NSCLC and metastatic cervical cancer. Pending approval in Russia for melanoma in 2019. For marketing authorization in EU BIOCAD is starting Phase III clinical trials.